Polyneuron raises CHF 22.5 million in Series A financing
Polyneuron Pharmaceuticals, one of our portfolio companies has successfully raised 22.5 million francs in a round of financing. The Basel-based company will use the proceeds…
Jérémie Meyer04.03.2020